Ixazomib Citrate
Brand name: Ninlaro
Rank #176 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$89.0M
Total Cost
6,901
Total Claims
$89.0M
Total Cost
348
Prescribers
$13K
Cost per Claim
42
Beneficiaries
6,938
30-Day Fills
$256K
Avg Cost/Provider
20
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$89.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $89.0M total
🔎 Data Overview
At $12,896 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $255,726 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $2,118,875 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Ixazomib Citrate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Frances Bell | Nurse Practitioner | New York, NY | 108 | $1.4M |
| 2 | Teresa Fogaren | Nurse Practitioner | Boston, MA | 74 | $953K |
| 3 | Larry Anderson | Hematopoietic Cell Transplantation and Cellular Therapy | Dallas, TX | 73 | $932K |
| 4 | Jonathan Kaufman | Hematology-Oncology | Atlanta, GA | 69 | $924K |
| 5 | Shahrooz Eshaghian | Hematology-Oncology | Los Angeles, CA | 65 | $899K |
| 6 | David Masiello | Hematology-Oncology | Los Angeles, CA | 69 | $874K |
| 7 | Kim Zawodni | Nurse Practitioner | Ann Arbor, MI | 64 | $833K |
| 8 | Christopher Alexander | Hematology-Oncology | Ormond Beach, FL | 61 | $812K |
| 9 | Alexis Cruz-Chacon | Hematology-Oncology | San Juan, PR | 62 | $786K |
| 10 | Nisha Joseph | Medical Oncology | Atlanta, GA | 56 | $764K |
| 11 | Suzan Rosen | Nurse Practitioner | Miami, FL | 58 | $730K |
| 12 | Naim Bideiwy | Nurse Practitioner | New York, NY | 46 | $664K |
| 13 | Bogdan Dumitriu | Internal Medicine | Upper Marlboro, MD | 53 | $663K |
| 14 | Muhammad Hussain | Hematology-Oncology | Albany, NY | 50 | $643K |
| 15 | Sharif Khan | Hematology | Greenville, SC | 46 | $628K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 173 | Lacosamide (Lacosamide) | $90.1M | 300,038 |
| 174 | Mepolizumab (Nucala) | $90.1M | 20,798 |
| 175 | Finerenone (Kerendia) | $89.5M | 93,151 |
| 176 | Ixazomib Citrate (Ninlaro) | $89.0M | 6,901 |
| 177 | Lamotrigine (Lamotrigine) | $89.0M | 1,603,798 |
| 178 | Insulin Aspart Prot/Insuln Asp (Novolog Mix 70-30 Flexpen) | $88.8M | 79,814 |
| 179 | Teduglutide (Gattex) | $88.4M | 1,758 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology